US 12077522
Heterocyclic compound and application thereof
granted A61KA61K31/445A61K31/506
Quick answer
US patent 12077522 (Heterocyclic compound and application thereof) held by Takeda Pharmaceutical Company Limited expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/445, A61K31/506, A61P, A61P25/00